Literature DB >> 26947079

CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection.

Changying Jiang1, Zhicheng Zhou2, Yanping Quan1, Shilei Zhang3, Tingting Wang1, Xueqiang Zhao3, Clayton Morrison4, Mark T Heise4, Wenqian He5, Matthew S Miller6, Xin Lin7.   

Abstract

Host response to RNA virus infection is sensed by RNA sensors such as RIG-I, which induces MAVS-mediated NF-κB and IRF3 activation to promote inflammatory and antiviral responses, respectively. Here, we have found that CARMA3, a scaffold protein previously shown to mediate NF-κB activation induced by GPCR and EGFR, positively regulates MAVS-induced NF-κB activation. However, our data suggest that CARMA3 sequesters MAVS from forming high-molecular-weight aggregates, thereby suppressing TBK1/IRF3 activation. Interestingly, following NF-κB activation upon virus infection, CARMA3 is targeted for proteasome-dependent degradation, which releases MAVS to activate IRF3. When challenged with vesicular stomatitis virus or influenza A virus, CARMA3-deficient mice showed reduced disease symptoms compared to those of wild-type mice as a result of less inflammation and a stronger ability to clear infected virus. Altogether, our results reveal the role of CARMA3 in regulating the balance of host antiviral and pro-inflammatory responses against RNA virus infection.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CARD10; CARMA3; IRF3; NF-κB; viral infection

Mesh:

Substances:

Year:  2016        PMID: 26947079      PMCID: PMC5842788          DOI: 10.1016/j.celrep.2016.02.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  48 in total

1.  Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.

Authors:  O Gaide; F Martinon; O Micheau; D Bonnet; M Thome; J Tschopp
Journal:  FEBS Lett       Date:  2001-05-11       Impact factor: 4.124

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

3.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

4.  IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines.

Authors:  Sabita Sankar; Henry Chan; William J Romanow; Jianwu Li; R J Bates
Journal:  Cell Signal       Date:  2005-09-30       Impact factor: 4.315

5.  CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.

Authors:  Linda M McAllister-Lucas; Jürgen Ruland; Katy Siu; Xiaohong Jin; Shufang Gu; David S L Kim; Peter Kuffa; Dawn Kohrt; Tak W Mak; Gabriel Nuñez; Peter C Lucas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

6.  TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.

Authors:  Marzenna Blonska; Prashant B Shambharkar; Masayuki Kobayashi; Dongyu Zhang; Hiroaki Sakurai; Bing Su; Xin Lin
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

7.  The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

Authors:  Constantin S Friedman; Marie Anne O'Donnell; Diana Legarda-Addison; Aylwin Ng; Washington B Cárdenas; Jacob S Yount; Thomas M Moran; Christopher F Basler; Akihiko Komuro; Curt M Horvath; Ramnik Xavier; Adrian T Ting
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

Review 8.  Epithelial growth factor receptor-activated nuclear factor κB signaling and its role in epithelial growth factor receptor-associated tumors.

Authors:  Deng Pan; Xin Lin
Journal:  Cancer J       Date:  2013 Nov-Dec       Impact factor: 3.360

9.  Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Authors:  Martin T Ferris; David L Aylor; Daniel Bottomly; Alan C Whitmore; Lauri D Aicher; Timothy A Bell; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Lisa E Gralinski; Bart L Haagmans; Leonard McMillan; Darla R Miller; Elizabeth Rosenzweig; William Valdar; Jeremy Wang; Gary A Churchill; David W Threadgill; Shannon K McWeeney; Michael G Katze; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

10.  IL-1 β and IL-6 upregulation in children with H1N1 influenza virus infection.

Authors:  Antonio Chiaretti; Silvia Pulitanò; Giovanni Barone; Pietro Ferrara; Valerio Romano; Domenico Capozzi; Riccardo Riccardi
Journal:  Mediators Inflamm       Date:  2013-04-29       Impact factor: 4.711

View more
  13 in total

1.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  Bcl10 phosphorylation-dependent droplet-like condensation positively regulates DNA virus-induced innate immune signaling.

Authors:  Dandan Yang; Gaofeng Pei; Shuangshuang Dong; Wenhao Zhang; Haiteng Deng; Xueqiang Zhao; Pilong Li; Xin Lin
Journal:  Sci China Life Sci       Date:  2022-09-15       Impact factor: 10.372

3.  CARD19, the protein formerly known as BinCARD, is a mitochondrial protein that does not regulate Bcl10-dependent NF-κB activation after TCR engagement.

Authors:  Kariana E Rios; Anuj K Kashyap; Sean K Maynard; Michael Washington; Suman Paul; Brian C Schaefer
Journal:  Cell Immunol       Date:  2020-07-29       Impact factor: 4.868

4.  The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.

Authors:  Shilei Zhang; Deng Pan; Xin-Ming Jia; Xin Lin; Xueqiang Zhao
Journal:  Protein Cell       Date:  2017-11       Impact factor: 14.870

Review 5.  CARMA3: Scaffold Protein Involved in NF-κB Signaling.

Authors:  Shilei Zhang; Xin Lin
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

6.  CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.

Authors:  Hui Hou; Wei-Xiang Li; Xiao Cui; Da-Chen Zhou; Bin Zhang; Xiao-Ping Geng
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

7.  CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.

Authors:  Longfei Peng; Ke He; Zhangjun Cao; Liangkuan Bi; Dexin Yu; Qi Wang; Jinyou Wang
Journal:  Mol Med Rep       Date:  2019-11-21       Impact factor: 2.952

8.  TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO.

Authors:  Zhou Yu; Xuelian Li; Mingjin Yang; Jiaying Huang; Qian Fang; Jianjun Jia; Zheng Li; Yan Gu; Taoyong Chen; Xuetao Cao
Journal:  Signal Transduct Target Ther       Date:  2021-02-28

9.  UBAC1/KPC2 Regulates TLR3 Signaling in Human Keratinocytes through Functional Interaction with the CARD14/CARMA2sh-TANK Complex.

Authors:  Pellegrino Mazzone; Michele Congestrì; Ivan Scudiero; Immacolata Polvere; Serena Voccola; Lucrezia Zerillo; Gianluca Telesio; Pasquale Vito; Romania Stilo; Tiziana Zotti
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

10.  Staphylococcus aureus Induces IFN-β Production via a CARMA3-Independent Mechanism.

Authors:  Yang Zhou; Shasha Zhao; Xiao Gao; Songhong Jiang; Jialu Ma; Rui Wang; Qing Li; Leiying Qin; Zhizi Tong; Junwei Wu; Jianjun Zhao
Journal:  Pathogens       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.